Antioxidant activity pathways (null)

Molecular Classification

Enzyme, Transcription factor, Small molecule antioxidant

Other Names

antioxidant pathways, antioxidant mechanisms, antioxidant defense systems, oxidative stress response pathways

Disease Roles

Cancer (oxidative stress implicated in carcinogenesis)Neurodegenerative disease (e.g., Alzheimer's, Parkinson's)Cardiovascular disease

Antioxidant activity pathways Overview

Antioxidant activity pathways refers to the collection of biochemical processes and molecular entities by which cells and organisms defend against oxidative damage caused by reactive oxygen species (ROS) and other free radicals. These pathways involve endogenous antioxidant enzymes such as superoxide dismutase, catalase, and glutathione peroxidase, as well as transcriptional regulation (primarily by Nrf2), and the action of small molecule antioxidants like vitamins and phytochemicals[1][2][3][4][5]. Collectively, these pathways mitigate the harmful effects of ROS, maintain redox homeostasis, and play central roles in the prevention of various diseases associated with oxidative stress, including cancer, neurodegeneration, cardiovascular disease, and age-related disorders[1][2][3][4]. The term itself is not a specific drug target but encompasses a broad class of molecular mechanisms.

Mechanism of Action

The mechanism of action for interventions related to antioxidant activity pathways includes free radical scavenging, metal ion chelation, upregulation of endogenous antioxidant enzymes (via Nrf2 activation), inhibition of oxidase enzymes (e.g., NADPH oxidase, xanthine oxidase), and decomposition of peroxides.

Biological Functions

Neutralization of free radicals

Regulation of oxidative stress

Protection of cells/tissues from damage

Signal transduction (via redox-sensitive transcription factors such as Nrf2)

Cell survival and apoptosis modulation

Disease Associations

Cancer (oxidative stress implicated in carcinogenesis)

Neurodegenerative disease (e.g., Alzheimer's, Parkinson's)

Cardiovascular disease

Inflammation

Aging-related disorders

Other (many chronic and metabolic diseases)

Safety Considerations

Excessive antioxidant supplementation may interfere with physiological redox signaling
Pro-oxidant effects of antioxidants in certain contexts (e.g., vitamin C with transition metals)
Unanticipated effects due to complex pathway interactions and dose-dependent toxicity

Interacting Drugs

Antioxidants (e.g., vitamin C, vitamin E, selenium, flavonoids, polyphenols)

Molecules targeting Nrf2 pathway (indirect modulators)

Enzyme mimetics (e.g., SOD mimetics)

Associated Biomarkers

Biomarker
Levels of antioxidant enzymes (SOD, catalase, glutathione peroxidase)
Oxidative stress markers (8-OHdG, MDA, protein carbonyls)
Reduced/oxidized glutathione ratio
Expression/activity of Nrf2 and downstream genes